Boothbay Fund Management, LLC Adicet Bio, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.26 - $20.81 $373,443 - $757,442	-36,398 Reduced 71.77%	14,317 $209,000
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $86,088 - $204,300	11,681 Added 29.93%	50,715 $887,000
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $17,215 - $27,178	2,737 Added 7.54%	39,034 $306,000
Q2 2021 Aug 16, 2021	SELL	$9.19 - $15.93 $54,606 - $94,656	-5,942 Reduced 14.07%	36,297 $120,000
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $205,603 - $291,271	16,964 Added 67.12%	42,239 $230,000
Q4 2020 Feb 12, 2021	BUY	$10.36 - $14.77 $6,133 - $8,743	592 Added 2.4%	25,275 $355,000
Q3 2020 Nov 16, 2020	BUY	$10.18 - $21.4 $251,272 - $528,216	24,683 New	24,683 $293,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.